Search Results - (( significant decrease decrease ) OR ( significant risks decrease ))~

Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant risks » significant risk (Expand Search), significant results (Expand Search), significant role (Expand Search)
risks decrease » sizes decrease (Expand Search), visits decreased (Expand Search), rivers decreased (Expand Search)

1821

All data extracted. by Xuqin Du (8803772)

Published 2025
“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], p = 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], p = 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], p = 0.000), and PaO2 (MD = 9.62, 95% CI [6.17, 13.08], p = 0.000), and a decrease in PaCO2 (MD = -9.12, 95% CI [–11.96, –6.28], p = 0.000). …”

Save to List

Saved in:
1822

Forest plot for TNF- by Xuqin Du (8803772)

Published 2025
“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], p = 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], p = 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], p = 0.000), and PaO2 (MD = 9.62, 95% CI [6.17, 13.08], p = 0.000), and a decrease in PaCO2 (MD = -9.12, 95% CI [–11.96, –6.28], p = 0.000). …”

Save to List

Saved in:
1823

Forest plot for hs-CRP. by Xuqin Du (8803772)

Published 2025
“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], p = 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], p = 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], p = 0.000), and PaO2 (MD = 9.62, 95% CI [6.17, 13.08], p = 0.000), and a decrease in PaCO2 (MD = -9.12, 95% CI [–11.96, –6.28], p = 0.000). …”

Save to List

Saved in:
1824

Forest plot for IL-6. by Xuqin Du (8803772)

Published 2025
“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], p = 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], p = 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], p = 0.000), and PaO2 (MD = 9.62, 95% CI [6.17, 13.08], p = 0.000), and a decrease in PaCO2 (MD = -9.12, 95% CI [–11.96, –6.28], p = 0.000). …”

Save to List

Saved in:
1825

The incidence rate of adverse reactions. by Xuqin Du (8803772)

Published 2025
“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], p = 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], p = 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], p = 0.000), and PaO2 (MD = 9.62, 95% CI [6.17, 13.08], p = 0.000), and a decrease in PaCO2 (MD = -9.12, 95% CI [–11.96, –6.28], p = 0.000). …”

Save to List

Saved in:
1826

The PRISMA study flowchart. by Xuqin Du (8803772)

Published 2025
“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], p = 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], p = 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], p = 0.000), and PaO2 (MD = 9.62, 95% CI [6.17, 13.08], p = 0.000), and a decrease in PaCO2 (MD = -9.12, 95% CI [–11.96, –6.28], p = 0.000). …”

Save to List

Saved in:
1827

Forest plot for FEV1/FVC. by Xuqin Du (8803772)

Published 2025
“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], p = 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], p = 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], p = 0.000), and PaO2 (MD = 9.62, 95% CI [6.17, 13.08], p = 0.000), and a decrease in PaCO2 (MD = -9.12, 95% CI [–11.96, –6.28], p = 0.000). …”

Save to List

Saved in:
1828

Forest plot for clinical efficacy. by Xuqin Du (8803772)

Published 2025
“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], p = 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], p = 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], p = 0.000), and PaO2 (MD = 9.62, 95% CI [6.17, 13.08], p = 0.000), and a decrease in PaCO2 (MD = -9.12, 95% CI [–11.96, –6.28], p = 0.000). …”

Save to List

Saved in:
1829

Forest plot for FEV1. by Xuqin Du (8803772)

Published 2025
“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], p = 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], p = 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], p = 0.000), and PaO2 (MD = 9.62, 95% CI [6.17, 13.08], p = 0.000), and a decrease in PaCO2 (MD = -9.12, 95% CI [–11.96, –6.28], p = 0.000). …”

Save to List

Saved in:
1830

The excluded and included studies were listed. by Xuqin Du (8803772)

Published 2025
“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], p = 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], p = 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], p = 0.000), and PaO2 (MD = 9.62, 95% CI [6.17, 13.08], p = 0.000), and a decrease in PaCO2 (MD = -9.12, 95% CI [–11.96, –6.28], p = 0.000). …”

Save to List

Saved in:
1831

Forest plot for PaCO2. by Xuqin Du (8803772)

Published 2025
“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], p = 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], p = 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], p = 0.000), and PaO2 (MD = 9.62, 95% CI [6.17, 13.08], p = 0.000), and a decrease in PaCO2 (MD = -9.12, 95% CI [–11.96, –6.28], p = 0.000). …”

Save to List

Saved in:
1832

Forest plot for PaO2. by Xuqin Du (8803772)

Published 2025
“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], p = 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], p = 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], p = 0.000), and PaO2 (MD = 9.62, 95% CI [6.17, 13.08], p = 0.000), and a decrease in PaCO2 (MD = -9.12, 95% CI [–11.96, –6.28], p = 0.000). …”

Save to List

Saved in:
1833

The timeline of the experiment. by Shadi Nazarizadeh (20108029)

Published 2024
“…EEG power in the HINS group decreased significantly compared to other experimental groups (p<0.05). …”

Save to List

Saved in:
1834

S1 Raw data - by Shadi Nazarizadeh (20108029)

Published 2024
“…EEG power in the HINS group decreased significantly compared to other experimental groups (p<0.05). …”

Save to List

Saved in:
1835

S1 Graphical abstract - by Shadi Nazarizadeh (20108029)

Published 2024
“…EEG power in the HINS group decreased significantly compared to other experimental groups (p<0.05). …”

Save to List

Saved in:
1836

Molecular docking results of CXCR4-modulator 1 with CXCR4 protein using PyRx software. by Bonoshree Sarkar (20469331)

Published 2024

Save to List

Saved in:
1837

RE-AIM indicators. by Gadapani Barsha Pathak (20700684)

Published 2025
“…If successful, this model can significantly improve stillbirth prevention in low-resource settings.…”

Save to List

Saved in:
1838

Logic model based on ERIC-CFIR. by Gadapani Barsha Pathak (20700684)

Published 2025
“…If successful, this model can significantly improve stillbirth prevention in low-resource settings.…”

Save to List

Saved in:
1839

Structural analysis of wild type and mutated variants of CXCR4. by Bonoshree Sarkar (20469331)

Published 2024

Save to List

Saved in:
1840

Supplementary Material for: The Impact of Changes in Fasting Plasma Glucose Before and After Heart Failure Diagnosis on All-Cause Mortality by figshare admin karger (2628495)

Published 2025
“…FPG levels were measured before and after HF diagnosis and categorized into five groups: significant decrease (Q1), mild decrease (Q2), stable (Q3), mild increase (Q4), and significant increase (Q5). …”

Save to List

Saved in: